196 related articles for article (PubMed ID: 23468991)
1. Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.
Schreiber C; Kuch V; Umansky V; Sleeman JP
PLoS One; 2013; 8(2):e57465. PubMed ID: 23468991
[TBL] [Abstract][Full Text] [Related]
2. Phenotypical and ultrastructural features of Oct4-positive cells in the adult mouse lung.
Galiger C; Kostin S; Golec A; Ahlbrecht K; Becker S; Gherghiceanu M; Popescu LM; Morty RE; Seeger W; Voswinckel R
J Cell Mol Med; 2014 Jul; 18(7):1321-33. PubMed ID: 24889158
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
4. Cell growth arrest and apoptosis induced by Oct4 or Nanog knockdown in mouse embryonic stem cells: a possible role of Trp53.
Chen T; Du J; Lu G
Mol Biol Rep; 2012 Feb; 39(2):1855-61. PubMed ID: 21706347
[TBL] [Abstract][Full Text] [Related]
5. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
6. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
8. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
[TBL] [Abstract][Full Text] [Related]
10. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells.
Zheng Q; Banaszak L; Fracci S; Basali D; Dunlap SM; Hursting SD; Rich JN; Hjlemeland AB; Vasanji A; Berger NA; Lathia JD; Reizes O
Endocr Relat Cancer; 2013 Dec; 20(6):797-808. PubMed ID: 24025407
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of nanog by OCT4 and SOX2.
Rodda DJ; Chew JL; Lim LH; Loh YH; Wang B; Ng HH; Robson P
J Biol Chem; 2005 Jul; 280(26):24731-7. PubMed ID: 15860457
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Nanog and Sox-2 genes following ectopic expression of Oct-4 in amniotic fluid mesenchymal stem cells.
Wang KH; Kao AP; Chang CC; Lin TC; Kuo TC
Biotechnol Appl Biochem; 2015; 62(5):591-7. PubMed ID: 25385323
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
Carey TS; Choi I; Wilson CA; Floer M; Knott JG
Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
15. Allelic expression and DNA methylation profiles of promoters at the parental Oct4 and Nanog genes in Mus musculus ES cell/Mus caroli splenocyte hybrid cells.
Battulin NR; Pristyazhnyuk IE; Matveeva NM; Fishman VS; Vasilkova AA; Serov OL
Cell Tissue Res; 2009 Sep; 337(3):439-48. PubMed ID: 19609564
[TBL] [Abstract][Full Text] [Related]
16. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal.
Pan G; Li J; Zhou Y; Zheng H; Pei D
FASEB J; 2006 Aug; 20(10):1730-2. PubMed ID: 16790525
[TBL] [Abstract][Full Text] [Related]
17. Nocodazole treatment decreases expression of pluripotency markers Nanog and Oct4 in human embryonic stem cells.
Kallas A; Pook M; Maimets M; Zimmermann K; Maimets T
PLoS One; 2011 Apr; 6(4):e19114. PubMed ID: 21559451
[TBL] [Abstract][Full Text] [Related]
18. Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.
Sun LT; Yamaguchi S; Hirano K; Ichisaka T; Kuroda T; Tada T
Dev Biol; 2014 Aug; 392(2):182-92. PubMed ID: 24929238
[TBL] [Abstract][Full Text] [Related]
19. Effect of vitrification on promoter methylation and the expression of pluripotency and differentiation genes in mouse blastocysts.
Zhao XM; Du WH; Hao HS; Wang D; Qin T; Liu Y; Zhu HB
Mol Reprod Dev; 2012 Jul; 79(7):445-50. PubMed ID: 22618890
[TBL] [Abstract][Full Text] [Related]
20. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
